Associationofdoor-to-balloontimeandmortalityinpatients admittedtohospitalwithSTelevationmyocardialinfarction: national cohort study

Objective To evaluate the association between door-toballoon time and mortality in hospital in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction to assess the incremental mortality benefit of reductions in door-toballoon times of less than 90 minutes. Design Prospective cohort study of patients enrolled in

[1]  H. Krumholz,et al.  A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality. , 2008, JACC. Cardiovascular interventions.

[2]  J. J. Griffin,et al.  Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. , 2007, The American journal of cardiology.

[3]  R. Gibbons,et al.  Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). , 2007, The American journal of cardiology.

[4]  K. Eagle,et al.  Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events , 2006, Heart.

[5]  Harlan M Krumholz,et al.  Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. , 2006, Journal of the American College of Cardiology.

[6]  G. Stone,et al.  Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. , 2006, American heart journal.

[7]  B. Brodie,et al.  Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. , 2006, Journal of the American College of Cardiology.

[8]  Gregg W Stone,et al.  Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? , 2005, JAMA.

[9]  E. Lesaffre,et al.  Determinants of infarct size in non-human primates , 2005, Basic Research in Cardiology.

[10]  J. Ottervanger,et al.  Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. , 2004, European heart journal.

[11]  David O. Williams.  Treatment delayed is treatment denied. , 2004, Circulation.

[12]  Elliott M. Antman,et al.  Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts , 2004, Circulation.

[13]  H. Suryapranata,et al.  Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. , 2003, Journal of the American College of Cardiology.

[14]  S. Nekolla,et al.  Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis , 2003, Circulation.

[15]  J. Golmard,et al.  Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time , 2003 .

[16]  B. Brodie,et al.  Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. , 2003, American heart journal.

[17]  David Antoniucci,et al.  Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. , 2002, The American journal of cardiology.

[18]  William S Weintraub,et al.  Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. , 2002, Journal of the American College of Cardiology.

[19]  G. Stone,et al.  Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). , 2001, The American journal of cardiology.

[20]  C M Gibson,et al.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. , 2000, JAMA.

[21]  S. Kimmel,et al.  A simplified lesion classification for predicting success and complications of coronary angioplasty. Registry Committee of the Society for Cardiac Angiography and Intervention. , 2000, The American journal of cardiology.

[22]  B. Brodie,et al.  Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. , 1998, Journal of the American College of Cardiology.

[23]  H. Suryapranata,et al.  Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. , 1998, Journal of the American College of Cardiology.

[24]  J. O’Keefe,et al.  Lack of relationship between the time to reperfusion and short-term mortality after primary infarct angioplasty , 1998 .

[25]  E. Braunwald,et al.  Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. , 1993, Circulation.

[26]  J. Lowe,et al.  The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.